3Das A.Cost-effectiveness of different strategies of cytomeg alovirus prophylaxis in orthotopic liver transplant recipients[J].Hepatology,2000,31(2): 311-317.
4Torres A,Ewig S,Insausti J,et al.Etiology and microbial patterns of pulmonary infiltrates in patients wit h orthotopic liver transplantation[J].Chest,2000,117(2): 494-502.
5Singh N,Chang FY,Gayowski T,et al.Fever in liver transpla nt recipients in the intensive care unit[J].Clin Transplant,1999,13(6): 504 -511.
6Lohmann R,Langrehr JM,Klupp J,et al.Infect ious complications after orthotopic liver transplantation with different immunos uppressive induction regimens[J].Transplant Proc,2000,32: 537-538.
7Malkan G,Cattral MS,Humar A,et al.Lamivudine for hepati tis B in liver transplantation: a single-center experience[J].Transplantatio n,2000,69(7): 1403-1407.
8Keeffe EB.End-stage liv er disease and liver transplantation: role of lamivudine therapy in patients wit h chronic hepatitis B[J].J Med Virol,2000,61(3): 403-408.
